AbbVie Inc. (ABBV) Financials

ABBV Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 135.1 billion 141.0 billion
March 31, 2026 136.5 billion 143.1 billion
Dec. 31, 2025 134.0 billion 137.2 billion
Sept. 30, 2025 133.9 billion 136.5 billion

ABBV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 3.7 billion 166.0 million
March 31, 2026 3.6 billion 444.0 million
Dec. 31, 2025 4.9 billion 157.0 million
Sept. 30, 2025 7.5 billion 209.0 million

ABBV Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 3.6 billion
March 31, 2026 697.0 million
Dec. 31, 2025 1.8 billion
Sept. 30, 2025 188.0 million

ABBV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 6.6 billion 62.5 billion -
March 31, 2026 9.4 billion 64.5 billion -
Dec. 31, 2025 5.3 billion 59.6 billion 711.0 million
Sept. 30, 2025 5.7 billion 63.0 billion -

ABBV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 1.8 billion
March 31, 2026 1.8 billion
Dec. 31, 2025 1.8 billion
Sept. 30, 2025 1.8 billion

ABBV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 265.0 million 2.6 billion 3.6 billion -
March 31, 2026 265.0 million 2.5 billion 3.6 billion -
Dec. 31, 2025 329.0 million 2.6 billion 3.9 billion -
Sept. 30, 2025 504.0 million 2.3 billion 3.6 billion -

ABBV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 17.0 billion 2.6 billion
March 31, 2026 15.0 billion 4.2 billion
Dec. 31, 2025 16.6 billion 4.6 billion
Sept. 30, 2025 15.8 billion 5.3 billion

ABBV Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ABBV

Price: $264.56

52 week price:
189.40
267.47

Dividend Yield: 2.80%

5-year range yield:
2.80%
5.38%

Forward Dividend Yield: 2.61%

Payout Ratio: 207.36%

Payout Ratio Range:
-12509.09%
5836.11%

Dividend Per Share: 6.92 USD

Earnings Per Share: 3.57 USD

P/E Ratio: 68.96

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 6.2 million

Ebitda: 1.9 billion

Market Capitalization: 435.1 billion

Average Dividend Frequency: 4

Years Paying Dividends: 14

DGR3: 5.37%

DGR5: 7.03%

DGR10: 13.18%

Links: